# Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

> **NCT02766621** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 62 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-06823859
- **DRUG:** Placebo injection SC/IV

## Key facts

- **NCT ID:** NCT02766621
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-27
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-09-26
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02766621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02766621, "Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02766621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*